Barrington Research Maintains Outperform on ModivCare, Raises Price Target to $68
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky has maintained an 'Outperform' rating on ModivCare (NASDAQ:MODV) and raised the price target from $58 to $68.
November 06, 2023 | 4:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ModivCare's price target has been raised from $58 to $68 by Barrington Research, which maintains an 'Outperform' rating on the stock.
The raised price target and maintained 'Outperform' rating by Barrington Research indicates a positive outlook for ModivCare. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100